Skip to content

Month: June 2017

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Condition:   Alström SyndromeIntervention:   Drug: PBI-4050Sponsor:   ProMetic BioSciences Inc.Not yet recruiting – verified June 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Valproic Acid’s Effect Too Small in One-Year Clinical Trial

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Valproic Acid’s Effect Too Small in One-Year Clinical Trial However, researchers identify a potentially powerful endpoint for evaluating emerging therapies in future studies. Results from a clinical trial sponsored by the Foundation Fighting Blindness Clinical Research Institute (FFB-CRI)…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest